Trial intelligence / Profile preview

Phase I study of tovorafenib in Japanese paediatric patients with BRAF-altered low-grade glioma

jRCT2031250599Phase 1Recruiting

Sponsor

Ipsen

Start

Mar 2026

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1